HTK Solution Cardioplegia in Pediatric Patients: A Meta-analysis
The Thoracic and Cardiovascular Surgeon · 01.03.2026 · 74 (02) · 164-173
DOI: 10.1055/a-2461-3147 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.03.2026. Verfasst von Lorhayne Kerley Capuchinho Scalioni Galvao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Federal University of Minas Gerais Medicine School, Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Cardioplegic Solutions, Heart Arrest, Induced, Cardiac Surgical Procedures. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Cardioplegia, a therapy designed to induce reversible cardiac arrest, revolutionized cardiovascular surgery. Among the various pharmacological approaches is the histidine-tryptophan-ketoglutarate (HTK) solution. Despite numerous studies, no meta-analysis has investigated the efficacy of the HTK solution in the pediatric population. Therefore, we aim to conduct a meta-analysis comparing HTK and other cardioplegia solutions in pediatric patients undergoing cardiovascular surgery. PubMed, Embase, and Cochrane databases were searched from inception through April 2024. Endpoints were computed in odds ratios (OR) with 95% confidence intervals (CI) for dichotomous variables, whereas continuous variables were compared using mean differences (MD) with 95% CI. A total of 11 studies comprising 1,349 patients were included, of whom 677 (50.19%) received HTK cardioplegia. The results were similar between groups regarding mortality (OR 0.98; 95% CI 0.29, 3.29), length of hospital stay (MD 0.32 days; 95% CI −0.88, 1.51), Mechanical ventilation (MV) (MD −17.72 hours; 95% CI −51.29, 15.85), arrhythmias (OR 1.27; 95% CI 0.83, 1.95), and delayed sternal closure (OR 0.89; 95% 0.56, 1.43). However, transfusion volume was lower in the HTK group (MD −452.39; 95% CI −890.24, −14.53; p = 0.04). The use of HTK solution was demonstrated to be similar regarding its clinical efficacy to other approaches for cardioplegia, and it may present advantages to patients prone to hypervolemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Federal University of Minas Gerais Medicine School, Belo Horizonte, Brazil.
- UNICID, Sao Paulo, Brazil.
- UNIRIO, Rio de Janeiro, Brazil.
- UNICAMP, Campinas, Sao Paulo, Brazil.
- Prevent Senior Private Health Operator, Sao Paulo, Brazil.
ORCID-Profile: Lorhayne Kerley Capuchinho Scalioni Galvao
Zitieren
APA
Galvao, L. K. C. S., Santos, A. C. F. F., Santos, N. P. D., Zamora, F. V., Biavatti, B. B. V., Salles, J. P. C. E. A., & Mendonca, H. S. (2026). HTK Solution Cardioplegia in Pediatric Patients: A Meta-analysis. The Thoracic and Cardiovascular Surgeon, 74(02), 164-173. https://doi.org/10.1055/a-2461-3147
Vancouver
Galvao LKCS, Santos ACFF, Santos NPD, Zamora FV, Biavatti BBV, Salles JPCEA, et al. HTK Solution Cardioplegia in Pediatric Patients: A Meta-analysis. The Thoracic and Cardiovascular Surgeon. 2026;74(02):164-173. doi:10.1055/a-2461-3147
BibTeX
@article{Galvao2026,
author = {Galvao, Lorhayne Kerley Capuchinho Scalioni and Santos, Ana Clara Felix de Farias and Santos, Nicole Pimenta Dos and Zamora, Fernanda Valeriano and Biavatti, Belisa Brunow Ventura and Salles, João Pedro Costa Esteves Almuinha and Mendonca, Horbert Soares},
title = {HTK Solution Cardioplegia in Pediatric Patients: A Meta-analysis},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
volume = {74},
number = {02},
pages = {164--173},
doi = {10.1055/a-2461-3147}
}
EUVIMED